期刊文献+

α_(1A)-肾上腺素受体的同源模建及其对接研究 被引量:3

Homology modeling and docking research of Human α_(1A)-Adrenoceptors
原文传递
导出
摘要 以β2肾上腺素受体(2β-AR)为模板,采用同源模建和分子动力学模拟构建了人类α1A-肾上腺素受体(α1A-AR)的三维结构模型,并利用PROCHECK,PROSA和WHAT-IF评估了模型的合理性.所得的结构采用分子对接程序Flexidock与激动剂去甲肾上腺素和拮抗剂西罗多辛分别进行对接,结果表明,2种配基具有相似的结合位点,配体可与同源模型的氨基酸残基Asp 106,Ser 188和Ser 192产生氢键作用,进一步证实了模型的合理性.研究结果对于基于受体的α1-AR的激动剂和拮抗剂的药物开发具有理论指导意义. The three dimensional structure of human α1A-Adrenoceptors was modeled and refined using homology modeling and molecular dynamics simulation.The model was assessed by PROCHECK,PROSA and WHAT-IF methods,which confirmed that the obtained model was reliable.An agonist norepinephrine and an antagonist silodosin were docked into the refined structure by the molecular docking programs Flexidock.The results showed that the two ligands shared the similar binding cavity,which interact with the residues Asp106,Ser188 and Ser192 with H-bond.This work provides the theoretical guidance for the drug designing of agonist and antagonist of the α1A-Adrenoceptors for related diseases.
出处 《分子科学学报》 CAS CSCD 北大核心 2011年第6期431-434,共4页 Journal of Molecular Science
基金 广州市科技计划重大专项资助(批准号:2009A1-E011-7)
关键词 α1A-肾上腺素受体 同源模建 分子动力学 对接 激动剂和拮抗剂 α1A-adrenoceptors homology modeling molecular dynamics molecular docking agonist and antagonist
  • 相关文献

参考文献15

二级参考文献44

共引文献73

同被引文献30

  • 1吕加国,盛春泉,张珉,季海涛,张万年,周有骏,朱驹,蒋俊航.人顶体酶三维结构的同源模建及其与KF950的分子对接研究[J].化学学报,2006,64(10):1073-1078. 被引量:8
  • 2Kulig K, Malawska B. Trends in the development of new drugs for treatment of benign prostatic hyperplasia [ J ]. Curr Med Chem, 2006,13 (28) :3395 - 3416. 被引量:1
  • 3Bishop M J. Recent advances in the discovery of alphal- adrenoceptor agonists [ J ]. Curr Top Med Chem, 2007,7:135 - 145. 被引量:1
  • 4Doeherty J R. Subtypes of functional alphal-and alpha2- adrenoceptors [ J ]. Eur J Pharmcol, 1998,361 : 1 - 15. 被引量:1
  • 5Gauthier C, Seze-Goismier C, Rozec B. Beta 3-adrenoceptors in the cardiovascular system [ J ]. Clin Hemorheol Microcirc, 2007,37 : 193 - 204. 被引量:1
  • 6Price D T, Schwinn D A, Lomasney J W, et al. Identification, quantification, and localization of mRNA for three distinct alpha1 adrenergie receptor subtypes in human prostate [ J]. J Urel, 1993, 150 (2) :546 -551. 被引量:1
  • 7Wilt T J, Macdonald R, Nelson D. Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruetion:a systematic review of efficacy and adverse effects [ J l- J Uro1,2002,167 ( 1 ) : 177 - 183. 被引量:1
  • 8Zhao X,Chen M S,Huang B Y,et al. Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) Studies on < alpha > 1A-adrenergic receptor antagonists based on pharmacophore molecular alignment[ J ]. Int J Mol Sci,2011,12(10) :7022 -7037. 被引量:1
  • 9Zhao X, Yuan M, Huang B Y, et al. Ligand-based pharmacophore model of N-aryl and N-heteroaryl piperazine < alpha > 1A- adrenoceptors antagonists using GALAHAD [ J ]. J Mol Graph Model,2010,29 : 126 - 136. 被引量:1
  • 10Kenakin T P. The relative contribution of affinity and efficacy to agonist activity : organ selectivity of noradrenaline and oxymetazoline with reference to the classification of drug receptors ~J]. Br J Pharmac,1984,81:131 - 141. 被引量:1

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部